Flosonics Medical

Flosonics Medical was founded on the mission of improving patient care through technology enabled solutions and services that clinicians love. With deep expertise in ultrasound technology and critical care medicine, Flosonics Medical has developed a wireless, wearable Doppler ultrasound system to support clinicians’ decisions regarding fluid resuscitation and management. Flosonics was chosen out of hundreds of companies around the world to join the CAP program in March 2021 just after it had received regulatory clearance for its core technology – a wireless, wearable Doppler ultrasound sensor aimed at improving the management of critically ill patients.